Global comparator data signal “alarm bells” for UK Government, says APBI
pharmaphorum
JULY 27, 2022
Despite the UK’s potential as an international life sciences leader, it lags many competitors in a number of key metrics, including access to new medicines and global share of clinical trial recruitment. Access to medicines. Clinical trials and exports. in the same period. in the same period.
88 
Let's personalize your content